Austin breast cancer survivor: Why I went to UT MD Anderson for lymphedema treatment
I was diagnosed with stage II breast cancer in April 2019, after noticing a lump in my right breast between screening mammograms. I thought my treatment would be simple: I’d have seven rounds of chemotherapy and a double mastectomy near my home in Austin, and that would be the end of it.
But all three lymph nodes the surgeon removed from my right armpit ended up testing positive for the HER2 genetic mutation. I needed...
MD Anderson helps breast cancer survivor get back to her family
Stacia Folloder was nine years away from the recommended age to get her first mammogram when she was diagnosed with breast cancer at age 31...
What is triple-positive breast cancer? 6 insights
Triple-positive breast cancer is a type of breast cancer that occurs when breast cancer cells use estrogen receptors, progesterone receptors...
Antibody drug conjugates: A shift in treatment options for solid tumors
Antibody drug conjugates have existed for years, but several recent advances are helping to refine how these cancer drugs work, expanding our understanding to help overcome their challenges and, ultimately, extending their benefit to more patients.
“Antibody drug conjugates are an exciting field of drug development,” says Funda Meric-Bernstam, M.D., chair of Investigational Cancer Therapeutics.
Antibody drug conjugates target...
Breast cancer survivor grateful for MD Anderson’s care
In August 2021, Dawn Patrick found a lump underneath her arm while in the shower. She immediately made an appointment with her primary care...
HER2-positive breast cancer survivor: I believe in MD Anderson
Jennifer Smith didn’t come to MD Anderson first for her breast cancer treatment, but she wishes she had. After she’d undergone treatment at...